The results suggest that expression of COX-2 is associated with lymph node metastasis and disease progression in NPC, indicating a potential role in evaluation of prognosis and in treatment decisions. The gene discussed is PTGS2; the disease is metastatic malignant neoplasm in the lymph nodes.